Comment on

• Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients.

  Mayer TA, Bersoff-Matcha S, Murphy C, Earls J, Harper S, Pauze D, Nguyen M, Rosenthal J, Cerva D Jr, Druckenbrod G, Hanfling D, Fatteh N, Napoli A, Nayyar A, Berman EL. Mayer TA, et al. JAMA. 2001 Nov 28;286(20):2549-53. doi: 10.1001/jama.286.20.2549. JAMA. 2001. PMID: 11722268
• Death due to bioterrorism-related inhalational anthrax: report of 2 patients.

  Borio L, Frank D, Mani V, Chiriboga C, Pollanen M, Ripple M, Ali S, DiAngelo C, Lee J, Arden J, Titus J, Fowler D, O'Toole T, Masur H, Bartlett J, Inglesby T. Borio L, et al. JAMA. 2001 Nov 28;286(20):2554-9. doi: 10.1001/jama.286.20.2554. JAMA. 2001. PMID: 11722269